Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
Mesenchymal stem cells (MSCs) possess pleiotropic properties that include immunomodulation, inhibition of apoptosis, fibrosis and oxidative stress, secretion of trophic factors, and enhancement of angiogenesis. These properties provide a broad spectrum for their potential in a wide range of injuries...
Saved in:
Main Authors: | Janaina Paulini (Author), Eliza Higuti (Author), Rosana M. C. Bastos (Author), Samirah A. Gomes (Author), Érika B. Rangel (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel strategy employing the flavonoid fisetin to halt the progression of renal fibrosis in obstructive nephropathy
by: Tae-Hwan Kwon
Published: (2023) -
Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury
by: Yuxiang Liu, et al.
Published: (2020) -
Mesenchymal Stem Cells: An Overview of Their Potential in Cell-Based Therapy for Diabetic Nephropathy
by: Yan Wu, et al.
Published: (2021) -
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best?
by: Eva Vivian, et al.
Published: (2013) -
Reprogramming Tumor-Associated Macrophage Using Nanocarriers: New Perspectives to Halt Cancer Progression
by: Alyona B. Kuznetsova, et al.
Published: (2024)